Main container

Analisi retrospettiva dell’espressione di biomarcatori del Metabolismo Osseo e Osteonecrosi della mandibola (ONJ) in pazienti affetti da Tumore a Cellule Giganti (TCG) in terapia con Denosumab in protocollo AMG20062004

Title
Analisi retrospettiva dell’espressione di biomarcatori del Metabolismo Osseo e Osteonecrosi della mandibola (ONJ) in pazienti affetti da Tumore a Cellule Giganti (TCG) in terapia con Denosumab in protocollo AMG20062004
Code
MOOTS
Type
Osservazionale
Start Year
2022
Status
In Corso

Principal Investigator

Operational unit that carry out the study

Description

Tutti i medici oncologi dell'Osteoncologia sono co-investigator e quindi arruolano pazienti per questo studio.

Documents and Videos attachament

You might also be interested in

Clinical Trial
A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors
Read more
Clinical Trial
Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors
Read more
Content updated
02/04/2025 14:59